自在淋巴瘤中的矛盾作用和治疗潜力
Qian-Qian Yu1, Chuyun Quan2, Yijing Li3
1Department of Tumor Biobank, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.
British journal of haematology
|October 20, 2025
概括
自,一个细胞过程,在淋巴瘤的发展和进展中起着双重作用. 了解它的机制为治疗复发性或耐药性淋巴瘤提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
背景情况:
- 淋巴瘤是不同的血液癌症,具有具有挑战性的治疗结果,特别是复发/耐药病例.
- 复发性/耐药性淋巴瘤的潜在病原体尚未完全理解.
- 自,一种细胞自我降解过程,越来越多地被认为与淋巴细胞发育和癌症形成有关.
研究的目的:
- 在淋巴瘤的背景下,审查当前关于自机制和调节的知识.
- 探索自在淋巴发育和对治疗的反应中的多方面的作用.
- 讨论针对自的潜力,作为淋巴瘤治疗的治疗策略.
主要方法:
- 文献综述综合了最近关于自和淋巴瘤的研究.
- 对调查自细胞在正常淋巴细胞功能和癌症发展中的作用的研究进行分析.
- 对淋巴瘤模型中自调节疗法的临床前和临床数据的检查.
主要成果:
- 自在淋巴瘤中具有上下文依赖的功能,可能促进或抑制瘤生长.
- 自的作用根据淋巴瘤亚型,遗传突变和治疗干预措施而有所不同.
- 有证据表明,操纵自可以影响淋巴瘤细胞存活率和治疗反应.
结论:
- 自是淋巴瘤发病和进展的关键因素.
- 准自为开发新型淋巴瘤疗法提供了一个有希望的途径.
- 需要进一步的研究来阐明特定的治疗策略,包括在淋巴瘤中自调节.
相关概念视频
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome
8.8K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.8K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


